The Pathophysiology of Lymphoma: Signs and Symptoms That Are Identified

The pathophysiology of lymphoma refers to the process or processes going on inside the body that are sometimes reflected in the signs and symptoms that are identified as being indicative of lymphoma.

For example, swollen, painless lymph nodes are a symptom of lymphoma. Pathophysiology of lymphoma with this symptoms is that it becomes this way when cancerous lymphocytes do not die, as they are supposed to, but rather proliferate and collect at the lymph nodes.

In cases with 'bulky' disease or tumor masses, as the tumor grows in size it begins to cause problems with the surrounding tissues and organs, causing symptoms that can be indicative of lymphoma.

The Molecular Pathophysiology of Lymphoma

This subject is too specific and too technical for this entry, but in brief what it refers to is the process, at the molecular level, that is believed to result in a lymphocyte becoming cancerous. For instance, in follicular lymphoma, it is very common to find that a specific gene, known as BCL-2, has undergone chromosomal rearrangement—in other words, a structural change has occurred to that gene and is likely the reason it turned cancerous. As it develops, the pathophysiology of lymphoma often includes mutations of certain proteins that encode certain genes, such as p53 and p16. Since the gene encoded by p53 is a tumor suppressor gene, a mutation in p53 could mean that the ability of that gene to suppress tumor development is compromised.

Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap